C71T
CANCELLED SECTION 71
02/06/2026
Back to search
Official data from USPTO
BILHI
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
BILHI
ST13
US500000079244386Class
5, 9, 42, 44
Filing
79244386
Registration
5809424
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
38
Latest update
03/03/2026
Trademark type
Word
Nice classes
5, 9, 42, 44
Filing date
07/23/2018
Registration date
07/23/2019
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
02/06/2026
Last transaction
03/03/2026
Responsible office
United States Patent and Trademark Office
Status code
709
Official register
Principal Register
Drawing code
4
Owner type
34
Owner location
FR
Examiner
MACFARLANE, JAMES W
Law office
L40
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
G. B. (pessoa física)
Representatives
Lawrence H. Binderow BINDEROW LAW OFFICES
Technical classification
Nice Classes
Class 5Class 9Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
HUMAN AND VETERINARY MEDICINEDIAGNOSTIC PREPARATIONS FOR DIAGNOSING AND PREDICTING BILHARZIACANCERFIBROSISKELOID SCARCIRRHOSISDIABETESCARDIAC DISEASEFOR PREPARING SAMPLESMODIFYING AND MANIPULATING CELLS AND FOR MARKINGSEPARATINGISOLATINGREPRODUCING AND CLEANING BIOPOLYMERSNUCLEIC ACIDSPROTEINSMACROMOLECULES AND BIOLOGICALLY ACTIVE SUBSTANCES; CHEMICALBIOCHEMICAL AND BIOTECHNOLOGICAL REAGENTSSOLVENTS AND INDICATORSALL FOR MEDICAL PURPOSESFOR PREPARING SAMPLESMODIFYING AND MANIPULATING CELLSFOR MARKINGSEPARATINGISOLATINGREPRODUCING AND CLEANING BIOPOLYMERSNUCLEIC ACIDSPROTEINSMACROMOLECULES AND BIOLOGICALLY ACTIVE SUBSTANCES FOR DIAGNOSTIC USEALL FOR USE IN TREATINGDIAGNOSING AND PREDICTING BILHARZIACANCERFIBROSISKELOID SCARCIRRHOSISDIABETESCARDIAC DISEASE; KITS COMPRISING PHARMACEUTICAL PREPARATIONS FOR HUMAN OR VETERINARY MEDICAL DIAGNOSTIC USE FOR PREPARING SAMPLESMODIFYING AND MANIPULATING CELLS AND FOR MARKINGSEPARATINGISOLATINGREPRODUCING AND CLEANING BIOPOLYMERSNUCLEIC ACIDSPROTEINSMACROMOLECULES AND BIOLOGICALLY ACTIVE SUBSTANCESALL FOR USE IN TREATINGDIAGNOSING AND PREDICTING BILHARZIACANCERFIBROSISKELOID SCARCIRRHOSISDIABETESCARDIAC DISEASE; PREPARATIONS FOR DETECTING GENETIC PREDISPOSITIONS FOR MEDICAL USE
Class 9
SOFTWARE AND COMPUTER PROGRAMS FOR MEDICAL DIAGNOSIS; APPARATUS FOR PROCESSING MEDICAL DATA FOR DIAGNOSTIC PURPOSES; PROTECTION AND SECURITY EQUIPMENT FOR ESTABLISHING MEDICAL DIAGNOSTICS AND TESTSGLOVES FOR LABORATORY PURPOSESPROTECTIVE SUITS ESPECIALLY MADE FOR USE IN LABORATORIESPROTECTIVE MASKS AND SPECTACLES
Class 42
DEVELOPMENT OF NEW TECHNOLOGY FOR OTHERS IN THE FIELD OF GENETICS AND BIOTECHNOLOGY; DEVELOPMENT OF TOOLS IN THE FORM OF SOFTWARE FOR REGULATINGMODIFYING AND CHARACTERIZING THE STATUS OF DISEASES; SCIENTIFIC RESEARCH AND DEVELOPMENT OF BIOTECHNOLOGICAL PROCESSES FOR REGULATINGMODIFYING AND CHARACTERIZING THE STATUS OF DISEASES; RESEARCH AND DEVELOPMENT FOR OTHERS IN THE FIELD OF BIOTECHNOLOGY; CUSTOM MANUFACTURE AND SYNTHESIS OF DNABIOLOGICAL ORGANISMSCELLSVIRUSESPATHOGENS AND SPECIAL GENETICALLY MODIFIED CELLS ACCORDING TO SPECIFICATIONS PROVIDED BY OTHERS FOR THE PURPOSE OF SCIENTIFICMEDICAL AND/OR LABORATORY RESEARCH; RESEARCH AND DEVELOPMENT FOR OTHERS IN THE FIELD OF GENE THERAPYDNABIOLOGICAL ORGANISMSCELLSVIRUSESPATHOGENS AND SPECIAL GENETICALLY MODIFIED CELLS FOR SCIENTIFIC OR MEDICAL USE OR FOR RESEARCH; DEVELOPMENT AND DESIGN OF ALGORITHMSDIAGNOSTIC APPARATUSMETHODS AND COMPUTER SOFTWARE IN THE MEDICAL FIELD; SCIENTIFIC RESEARCH IN THE FIELD OF GENETICS AND GENETIC ENGINEERING; MEDICAL RESEARCH; GENETIC RESEARCH; BIOLOGICAL RESEARCH SERVICES; CONDUCTING CLINICAL TRIALS FOR OTHERS; RESEARCH AND DEVELOPMENT OF MEDICAL TREATMENTS AND MEDICINES
Class 44
MEDICAL DIAGNOSIS SERVICES; MEDICAL TESTING FOR THE DIAGNOSIS AND TREATMENT OF PERSONS; GENETIC ANALYSIS FOR MEDICAL USE; MEDICAL SCREENING; MEDICAL ADVICE REGARDING MEDICAL MATTERS; PROVIDING ON-LINE INFORMATION RELATING TO MEDICAL DIAGNOSIS AND DETECTION OF DISEASES
Publications
History of USPTO decisions and trademark events.
38 publications found
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
07/23/2024
NREP
NEW REPRESENTATIVE AT IB RECEIVED
06/17/2023
NREP
NEW REPRESENTATIVE AT IB RECEIVED
07/17/2021
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
12/06/2019
FICS
FINAL DISPOSITION NOTICE SENT TO IB
11/18/2019
FIMP
FINAL DISPOSITION PROCESSED
11/18/2019
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
10/23/2019
R.PR
REGISTERED-PRINCIPAL REGISTER
07/23/2019
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
05/07/2019
PUBO
PUBLISHED FOR OPPOSITION
05/07/2019
GPNX
NOTIFICATION PROCESSED BY IB
05/03/2019
CRSN
CORRECTION SENT TO IB
04/30/2019
CRCR
CORRECTION CREATED FOR IB
04/30/2019
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
04/17/2019
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
04/17/2019
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
04/17/2019
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/29/2019
RFNT
REFUSAL PROCESSED BY IB
03/29/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/27/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/27/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
03/19/2019
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
01/18/2019
GNRT
NON-FINAL ACTION E-MAILED
01/18/2019
CNRT
NON-FINAL ACTION WRITTEN
01/18/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
12/19/2018
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/19/2018
ALIE
ASSIGNED TO LIE
12/19/2018
RFNT
REFUSAL PROCESSED BY IB
12/15/2018
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
12/14/2018
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
11/27/2018
RFRR
REFUSAL PROCESSED BY MPU
11/27/2018
MAFR
APPLICATION FILING RECEIPT MAILED
11/13/2018
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
11/11/2018
CNRT
NON-FINAL ACTION WRITTEN
11/10/2018
DOCK
ASSIGNED TO EXAMINER
11/08/2018
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
11/07/2018
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
11/01/2018
Continuous trademark protection
Get notified about every new filing that threatens BILHI or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.